These mutations disrupt amyloid precursor protein (APP) processing, leading to abnormal cleavage by β- and γ-secretases and subsequent amyloid plaque formation, a hallmark of AD (Table 1 and Supplementary Figure S1A) [22,23]. The gene discussed is APP; the disease is Alzheimer disease.